HRT Financial’s Hepion Pharmaceuticals HEPA Stock Holding History

HRT Financial’s Portfolio HEPA Stock Details HEPA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-16,387	Closed	-$7K	–	2999
2025 Q1	$7K	Buy	+16,387	New	+$160K	﹤0.01%	2381
2021 Q4	–	Sell	-35	Closed	-$53K	–	3544
2021 Q3	$53K	Buy	35 +25	+250%	+$40K	﹤0.01%	3037
2021 Q2	$20K	Buy	+10	New	+$18.3K	﹤0.01%	2727

Other funds holding HEPA

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

HRT Financial's HEPA Position: Q2 2025 in Review

HRT Financial sold out of Hepion Pharmaceuticals (HEPA) in Q2 2025, closing a stake of 16,387 shares — an estimated $7K sold.

HRT Financial first reported a position in HEPA in Q2 2021 and held it in 3 quarters. The position peaked at $53K in Q3 2021. 4 funds tracked by Wall St. Rank hold HEPA as of Q2 2025.

HRT Financial reported no remaining Hepion Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
HRT Financial sold 16,387 Hepion Pharmaceuticals shares in Q2 2025, an estimated $7K.
HRT Financial first reported a position in Hepion Pharmaceuticals in Q2 2021 and held it in 3 quarters.
HRT Financial's Hepion Pharmaceuticals position peaked at $53K in Q3 2021.
4 funds tracked by Wall St. Rank held Hepion Pharmaceuticals as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.